Technical Ventures RX Corp. — Investor Relations & Filings
Technical Ventures RX Corp. was the corporate vehicle for a Qualifying Transaction completed in 2014, resulting in the acquisition of TheraVitae Inc. (TVI). The resulting clinical-stage biotechnology operation focuses on the development and commercialization of innovative, autologous (patient's own), blood-derived cell therapies. The company utilizes a proprietary technology platform engineered for the treatment of vascular diseases. Its lead clinical-stage candidate is ACP-01, an autologous cell therapy currently being advanced through clinical trials for vascular applications. This specialization in regenerative medicine leverages the patient's own biological material for personalized therapeutic interventions.
Recent filings
No filings indexed yet
We are still gathering filings for Technical Ventures RX Corp.. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
SpyGlass Pharma, Inc.
Ophthalmic biotech developing drug delivery integrated with…
|
SGP | US | Professional, scientific and te… |
|
SQI Diagnostics Inc.
Precision medicine biotech developing innovative diagnostic…
|
SQD.H | CA | Professional, scientific and te… |
|
STARPHARMA HOLDINGS LIMITED
Develops dendrimer technology for pharmaceutical and life s…
|
SPL | AU | Professional, scientific and te… |
|
Stayble Therapeutics AB
Develops treatments for chronic pain originating from spina…
|
STABL | SE | Professional, scientific and te… |
|
STCUBE
Develops immuno-oncology therapies targeting novel immune c…
|
052020 | KR | Professional, scientific and te… |
|
StemRIM Inc.
Develops regenerative medicine that uses the body's own ste…
|
4599 | JP | Professional, scientific and te… |
|
STRATEGIC ELEMENTS LIMITED
Develops printed electronics, autonomous systems, and AI fo…
|
SOR | AU | Professional, scientific and te… |
|
Sun Pharma Advanced Research Company Ltd.
Clinical-stage biopharmaceutical firm developing innovative…
|
SPARC | IN | Professional, scientific and te… |
|
Surrozen, Inc./DE
Develops drug candidates to selectively modulate the Wnt pa…
|
SRZN | US | Professional, scientific and te… |
|
Suven Life Sciences Ltd.
Develops novel therapeutic agents for Central Nervous Syste…
|
SUVEN | IN | Professional, scientific and te… |
Technical Ventures RX Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47051/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47051 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47051 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47051 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47051}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Technical Ventures RX Corp. (id: 47051)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.